Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7178
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHubo, Mario-
dc.contributor.authorTrinschek, Bettina-
dc.contributor.authorKryczanowsky, Fanny-
dc.contributor.authorTüttenberg, Andrea-
dc.contributor.authorSteinbrink, Kerstin-
dc.contributor.authorJonuleit, Helmut-
dc.date.accessioned2022-06-20T08:53:12Z-
dc.date.available2022-06-20T08:53:12Z-
dc.date.issued2013-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7192-
dc.description.abstractDendritic cells (DC) are sentinels of immunity, essential for homeostasis of T cell-dependent immune responses. Both functions of DC, initiation of antigen-specific T cell immunity and maintenance of tissue-specific tolerance originate from distinct stages of differentiation, immunogenic versus tolerogenic. Dependent on local micro milieu and inflammatory stimuli, tissue resident immature DC with functional plasticity differentiate into tolerogenic or immunogenic DC with stable phenotypes. They efficiently link innate and adaptive immunity and are ideally positioned to modify T cell-mediated immune responses. Since the T cell stimulatory properties of DC are significantly influenced by their expression of signal II ligands, it is critical to understand the impact of distinct costimulatory pathways on DC function. This review gives an overview of functional different human DC subsets with unique profiles of costimulatory molecules and outlines how different costimulatory pathways together with the immunosuppressive cytokine IL-10 bias immunogenic versus tolerogenic DC functions. Furthermore, we exemplarily describe protocols for the generation of two well-defined monocyte-derived DC subsets for their clinical use, immunogenic versus tolerogenic.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleCostimulatory molecules on immunogenic versus tolerogenic human dendritic cellsen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7178-
jgu.type.contenttypeReviewde
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleFrontiers in immunologyde
jgu.journal.volume4de
jgu.pages.alternative82de
jgu.publisher.year2013-
jgu.publisher.nameFrontiers Mediade
jgu.publisher.placeLausannede
jgu.publisher.urihttp://dx.doi.org/10.3389/fimmu.2013.00082de
jgu.publisher.issn1664-3224de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
opus.date.modified2018-07-31T09:43:33Z-
opus.subject.dfgcode04-204-
opus.organisation.stringFB 04: Medizin: Hautklinikde_DE
opus.identifier.opusid22809-
opus.institute.number0431-
opus.metadataonlyfalse-
opus.type.contenttypeÜbersichtsartikelde_DE
opus.type.contenttypeReview Articleen_EN
opus.affiliatedTüttenberg, Andrea-
opus.affiliatedSteinbrink, Kerstin-
opus.affiliatedJonuleit, Helmut-
jgu.publisher.doi10.3389/fimmu.2013.00082de
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
costimulatory_molecules_on_im-20220616170026506.pdf2.13 MBAdobe PDFView/Open